Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

17.44 +0.79 (+4.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 112 companies set new 52-week lows. 
Via Benzinga
3 Things About NovoCure That Smart Investors Know
Its cancer-treating device is struggling to find its market. 
Via The Motley Fool
Novocure Highlights Use of Tumor Treating Fields Therapy in Treatment of Non-Small Cell Lung Cancer at 2023 World Conference on Lung Cancer
From Novocure
Via Business Wire
Why Novocure Stock Fell 24.4% This Week
Novocure announced a disappointing outcome from a phase 3 clinical trial for a key cancer treatment. 
Via The Motley Fool
What 11 Analyst Ratings Have To Say About NovoCure
Via Benzinga
Why NovoCure Stock Is Crashing Today
The company disappointed investors with its latest clinical trial update. 
Via The Motley Fool
3 Healthcare Stocks to Sell in September Before They Crash & Burn
The prognosis for these healthcare stocks isn't optimistic so plan to sell them this month before they get worse. 
Via InvestorPlace
Down 31% in 1 Day, What's Next for NovoCure Stock?
It's entering a risky period, but it could persevere. 
Via The Motley Fool
Is NovoCure's Stock Headed for a Free Fall?
It can be hard to find a reason to remain bullish on NovoCure. 
Via The Motley Fool
Novocure Announces The Lancet Oncology Publishes Primary Data from Phase 3 LUNAR Clinical Trial in Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
From Novocure
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 99 stocks hit new 52-week lows. 
Via Benzinga
What's Going On With NovoCure Stock Today?
NovoCure Limited (NASDAQ: NVCR) shares are trading higher Tuesday. The stock appears to be recovering from a loss of over 30% on Monday. What To Know: 
Via Benzinga
PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Gains Over 100 Points; Hawaiian Electric Shares Surge
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to 34,490.80 while the NASDAQ rose 0.62% to 13,674.49. The S&P 500,... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Novocure (NVCR) Stock Down 30% Today?
Following Novocure’s disappointing late-stage clinical trial for its cancer-treating platform, NVCR stock stumbled on relevancy concerns. 
Via InvestorPlace
Why Is Cancer Focused-Novocure's Stock Plunging Today?
Novocure Ltd (NASDAQ: NVCR) shares are falling after the company's phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 clinical trial of Tumor Treating Fields (TTFields) together with paclitaxel in patients... 
Via Benzinga
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Rises; GD Culture Group Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 150 points on Monday. The Dow traded up 0.46% to 34,505.54 while the NASDAQ rose 0.43% to 13,649.27. The S&P 500, also... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
US Stocks Open Higher; Kimco Realty To Acquire RPT Realty
U.S. stocks traded higher this morning, with the Dow Jones gaining over 250 points on Monday. Following the market opening Monday, the Dow traded up 0.81% to 34,626.22 while the NASDAQ rose 0.61% to... 
Via Benzinga
Topics Stocks
Exposures US Equities
Novocure Plummets 34% After Its Cancer Treatment Fails In Ovarian Cancer
The company tested a regimen of chemotherapy and its tumor-treating fields. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Novocure Provides Update on Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 Trial Evaluating Tumor Treating Fields Therapy in Platinum-resistant Ovarian Cancer
From Novocure
Via Business Wire
Could NovoCure Stock Help You Become a Millionaire?
The stock has some significant upside, but it also comes with considerable risks and volatility. 
Via The Motley Fool
Novocure to Participate in Upcoming Investor Conferences
From Novocure
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)
From The Law Offices of Frank R. Cruz
Via Business Wire
NOVOCURE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NovoCure Limited and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Calling All NovoCure Limited (NVCR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit
New York, New York - Attorney Advertising – Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action 
Via Law Firm Newswire
Topics Lawsuit
Exposures Financial Legal
NOVOCURE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against NovoCure Limited - NVCR
From Kahn Swick & Foti, LLC
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.